APA (7th ed.) Citation

O, K., C, P., M, T., A, C., F, C., E, D., . . . B, T. (2024). VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulation. Nature communications, 15(1), 910. https://doi.org/10.1038/s41467-024-44811-4

Chicago Style (17th ed.) Citation

O, Kosmider, et al. "VEXAS Syndrome Is Characterized by Inflammasome Activation and Monocyte Dysregulation." Nature Communications 15, no. 1 (2024): 910. https://doi.org/10.1038/s41467-024-44811-4.

MLA (9th ed.) Citation

O, Kosmider, et al. "VEXAS Syndrome Is Characterized by Inflammasome Activation and Monocyte Dysregulation." Nature Communications, vol. 15, no. 1, 2024, p. 910, https://doi.org/10.1038/s41467-024-44811-4.